Home/Filings/4/0001415889-23-007687
4//SEC Filing

BIZZARI JEAN-PIERRE 4

Accession 0001415889-23-007687

CIK 0001159036other

Filed

May 8, 8:00 PM ET

Accepted

May 9, 6:09 PM ET

Size

7.5 KB

Accession

0001415889-23-007687

Insider Transaction Report

Form 4
Period: 2023-05-05
Transactions
  • Award

    Common Stock

    2023-05-05+8,06566,815 total
  • Award

    Option to Purchase Common Stock

    2023-05-05+11,37111,371 total
    Exercise: $31.00From: 2024-05-05Exp: 2033-05-05Common Stock (11,371 underlying)
Footnotes (2)
  • [F1]Represents annual restricted stock unit ("RSU") grant under the Issuer's director compensation program. Each RSU represents the right to receive one share of common stock of the Issuer. This grant will vest in full on the earlier of (i) May 5, 2024 and (ii) the date of the Issuer's next annual meeting of stockholders.
  • [F2]Represents annual stock option grant under the Issuer's director compensation program. This grant will vest in full on the earlier of (i) May 5, 2024 and (ii) the date of the Issuer's next annual meeting of stockholders.

Issuer

HALOZYME THERAPEUTICS, INC.

CIK 0001159036

Entity typeother

Related Parties

1
  • filerCIK 0001630914

Filing Metadata

Form type
4
Filed
May 8, 8:00 PM ET
Accepted
May 9, 6:09 PM ET
Size
7.5 KB